跳至主要内容
临床试验/NL-OMON51638
NL-OMON51638招募中不适用

Study on test-REtest reliability in Patients with inheritEd retinAl dysTrophies (REPEAT study) - REPEAT study

eids Universitair Medisch Centrum0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
16 至 99(—)

入选标准

  • In order to be eligible to participate in this study as a visually-impaired
  • patient, a subject must meet all of the following criteria:
  • Willing and able to provide informed consent (IC) for the participation in
  • Minimum age of 16 years;
  • Clinical diagnosis of IRD with BCVA using ETDRS of >=20/50 Snellen equivalent;
  • Willing and able to undergo ophthalmic examinations at two separate occasions;
  • No ocular or non-ocular disease/disorder that may influence the results of
  • the measurements.
  • In order to be eligible to participate in this study as a low-vision patient, a
  • subject must meet all of the following criteria:
  • Willing and able to provide informed consent (IC) for the participation in
  • Minimum age of 16 years;
  • Clinical diagnosis of IRD with BCVA using ETDRS of <20/50 Snellen equivalent;
  • Willing and able to undergo ophthalmic examinations at two separate occasions;
  • No ocular or non-ocular disease/disorder that may influence the results of
  • the measurements

排除标准

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study:
  • The last measured BCVA in the better-seeing eye is light-perception;
  • (History of) ocular of non-ocular disease/disorder that may influence the
  • results of the measurements (e.g. amblyopia);
  • Known allergy or intolerance for ocular anesthetic eye drops oxybuprocaine
  • 0.4% or mydriatics tropicamide 0.5% and/or phenylephrine 5%;
  • Participation in another research study involving an investigational
  • medicinal product related to their ocular health.

研究者

相似试验